Schonfeld Strategic Advisors’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-94,843	Closed	-$972K	–	2703
2023 Q1	$972K	Sell	94,843 -2,513	-3%	-$25.5K	0.01%	974
2022 Q4	$978K	Hold	97,356	–	–	0.01%	1161
2022 Q3	$959K	Buy	97,356 +47,475	+95%	+$466K	0.01%	1300
2022 Q2	$486K	Buy	+49,881	New	+$487K	﹤0.01%	1387

Schonfeld Strategic Advisors's ORIA Position: Q2 2023 in Review

Schonfeld Strategic Advisors sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 94,843 shares — an estimated $972K sold.

Schonfeld Strategic Advisors first reported a position in ORIA in Q2 2022 and held it in 4 quarters. The position peaked at $978K in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Schonfeld Strategic Advisors reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Schonfeld Strategic Advisors sold 94,843 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $972K.
Schonfeld Strategic Advisors first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q2 2022 and held it in 4 quarters.
Schonfeld Strategic Advisors's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $978K in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.